{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:47:48Z","timestamp":1771652868033,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:00:00Z","timestamp":1526688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competetive state research financing of the expert responsibility area of Tampere University Hospital","award":["9U019, 9T018, 9V017, 9T058, 9U053"],"award-info":[{"award-number":["9U019, 9T018, 9V017, 9T058, 9U053"]}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["xx"],"award-info":[{"award-number":["xx"]}],"id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Dermatitis herpetiformis (DH) is a cutaneous manifestation of coeliac disease. At diagnosis, the majority of patients have villous atrophy in the small bowel mucosa. The objective of this study was to investigate whether the presence or absence of villous atrophy at diagnosis affects the long-term prognosis of DH. Data were gathered from the patient records of 352 DH and 248 coeliac disease patients, and follow-up data via questionnaires from 181 DH and 128 coeliac disease patients on a gluten-free diet (GFD). Of the DH patients, 72% had villous atrophy when DH was diagnosed, and these patients were significantly younger at diagnosis compared to those with normal small bowel mucosa (37 vs. 54 years, p &lt; 0.001). Clinical recovery on a GFD did not differ significantly between the DH groups, nor did current adherence to a GFD, the presence of long-term illnesses, coeliac disease-related complications or gastrointestinal symptoms, or quality of life. By contrast, the coeliac disease controls had more often osteopenia\/osteoporosis, thyroid diseases, malignancies and current gastrointestinal symptoms compared to the DH patients. In conclusion, villous atrophy at the time of DH diagnosis does not have an impact on the clinical recovery or long-term general health of DH patients.<\/jats:p>","DOI":"10.3390\/nu10050641","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T04:07:30Z","timestamp":1526875650000},"page":"641","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis"],"prefix":"10.3390","volume":"10","author":[{"given":"Eriika","family":"Mansikka","sequence":"first","affiliation":[{"name":"Department of Dermatology, Tampere University Hospital, 33521 Tampere, Finland"},{"name":"Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Hervonen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tampere University Hospital, 33521 Tampere, Finland"},{"name":"Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Kaukinen","sequence":"additional","affiliation":[{"name":"Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, 33014 Tampere, Finland"},{"name":"Department of Internal Medicine, Tampere University Hospital, 33521 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Collin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, 33521 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-430X","authenticated-orcid":false,"given":"Heini","family":"Huhtala","sequence":"additional","affiliation":[{"name":"Faculty of Social Sciences, University of Tampere, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Reunala","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tampere University Hospital, 33521 Tampere, Finland"},{"name":"Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-4938","authenticated-orcid":false,"given":"Teea","family":"Salmi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tampere University Hospital, 33521 Tampere, Finland"},{"name":"Celiac Disease Research Center, Faculty of Medicine and Life Sciences, University of Tampere, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","article-title":"Prevalence and incidence of dermatitis herpetiformis: A 40-year prospective study from Finland","volume":"165","author":"Salmi","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ajg.2014.55","article-title":"Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: Population-based study","volume":"109","author":"West","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2010.09.777","article-title":"Dermatitis herpetiformis: Part I. Epidemiology, pathogenesis, and clinical presentation","volume":"64","author":"Bolotin","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","first-page":"29","article-title":"Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (\u03b11* 0501,(\u03b21* 02) or the HLA-DQ (\u03b11* 03,(\u03b21* 0302) heterodimers","volume":"49","author":"Spurkland","year":"1997","journal-title":"HLA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: A cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gut.2003.024836","article-title":"In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies","volume":"53","author":"Halttunen","year":"2004","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2340\/00015555-1764","article-title":"Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis","volume":"94","author":"Salmi","year":"2014","journal-title":"Acta Derm. Veneorol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1523-1747.1999.00627.x","article-title":"Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis","volume":"113","author":"Dieterich","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archderm.1996.03890320060010","article-title":"Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis","volume":"132","author":"Zone","year":"1996","journal-title":"Arch. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Merkl","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.jid.5701041","article-title":"Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue","volume":"128","author":"Marietta","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2133.2008.08629.x","article-title":"Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis","volume":"159","author":"Hull","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.dld.2016.03.003","article-title":"Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis","volume":"48","author":"Salmi","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0140-6736(66)91692-8","article-title":"Small-bowel changes in dermatitis herpetiformis","volume":"288","author":"Marks","year":"1966","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MCG.0000000000000533","article-title":"The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: A 45-year experience in 393 patients","volume":"51","author":"Mansikka","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.11.004","article-title":"Dermatitis herpetiformis: Close to unravelling a disease","volume":"34","year":"2004","journal-title":"J. Dermatol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2005.02.026","article-title":"Skin manifestations of celiac disease","volume":"128","author":"Zone","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0140-6736(73)91539-0","article-title":"Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal","volume":"301","author":"Fry","year":"1973","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0738-081X(91)90026-H","article-title":"Dermatitis herpetiformis: Autoimmune disease associations","volume":"9","author":"Kaplan","year":"1991","journal-title":"Clin. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2133.2004.05642.x","article-title":"The occurrence of type 1 diabetes in patients with dermatitis herpetiformis and their first-degree relatives","volume":"150","author":"Hervonen","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/gast.1999.0029900297","article-title":"Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease","volume":"117","author":"Ventura","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dld.2006.03.002","article-title":"Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study","volume":"38","author":"Viljamaa","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2133.2005.06345.x","article-title":"Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives","volume":"152","author":"Hervonen","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/00365529609095544","article-title":"Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease","volume":"31","author":"Carlsson","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","article-title":"GSRS\u2014A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease","volume":"33","author":"Svedlund","year":"1988","journal-title":"Dig. Dis. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ludvigsson, J.F., Ciacci, C., Green, P.H., Kaukinen, K., Korponay-Szabo, I.R., Kurppa, K., Murray, J.A., Lundin, K.E.A., Maki, M.J., and Popp, A. (2018). Outcome measures in coeliac disease trials: The Tampere recommendations. Gut.","DOI":"10.1136\/gutjnl-2017-314853"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gutjnl-2016-312762","article-title":"Disease activity indices in coeliac disease: Systematic review and recommendations for clinical trials","volume":"67","author":"Hindryckx","year":"2016","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dld.2006.01.004","article-title":"Psychological well-being of adult coeliac patients treated for 10 years","volume":"38","author":"Roos","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2036.2005.02574.x","article-title":"Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life","volume":"22","author":"Viljamaa","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2036.2009.03945.x","article-title":"Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet","volume":"29","author":"Hallert","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(67)91942-3","article-title":"Small-intestinal structure and function and haematological changes in dermatitis herpetiformis","volume":"290","author":"Fry","year":"1967","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2340\/00015555-2818","article-title":"Diagnostic delay in dermatitis herpetiformis in a high-prevalence area","volume":"98","author":"Mansikka","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1982.tb00520.x","article-title":"Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal","volume":"107","author":"Fry","year":"1982","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/gut.25.2.151","article-title":"Dermatitis herpetiformis: Diagnosis, diet and demography","volume":"25","author":"Gawkrodger","year":"1984","journal-title":"Gut"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","article-title":"Reduced mortality in dermatitis herpetiformis: A population-based study of 476 patients","volume":"167","author":"Hervonen","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2036.2011.04972.x","article-title":"Meta-analysis: Coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy","volume":"35","author":"Tio","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1997.tb14935.x","article-title":"Diseases associated with dermatitis herpetiformis","volume":"136","author":"Reunala","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40257-013-0051-7","article-title":"Dermatitis herpetiformis: Clinical presentations are independent of manifestations of celiac disease","volume":"15","author":"Krishnareddy","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40257-015-0149-1","article-title":"Quality of life and gastrointestinal symptoms in long-term treated dermatitis herpetiformis patients: A cross-sectional study in Finland","volume":"16","author":"Pasternack","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/gut.2005.071514","article-title":"Endomysial antibody-negative coeliac disease: Clinical characteristics and intestinal autoantibody deposits","volume":"55","author":"Salmi","year":"2006","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1572-0241.2008.01977.x","article-title":"Age-related clinical, serological, and histopathological features of celiac disease","volume":"103","author":"Vivas","year":"2008","journal-title":"Am. J. Gastroenterol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/5\/641\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:05:00Z","timestamp":1760195100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/5\/641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,19]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["nu10050641"],"URL":"https:\/\/doi.org\/10.3390\/nu10050641","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,19]]}}}